The Chemours Company is a specialty chemicals maker whose largest businesses span Titanium Technologies (TiO2 pigments), Thermal & Specialized Solutions (TSS, including refrigerants), and Advanced Performance Materials. Following a sharp share-price decline, several firms revised their price targets in early October 2026. Five recent, attributable targets form the basis of this analysis: RBC Capital at $14 (downgrade to Sector Perform, October 12–13), Mizuho at $15 (downgrade to Hold, October 13), Barclays at $16 (initiation, October 12), UBS at $16 (Neutral, October 5), and BMO Capital at $18 (Buy, October 5).
The arithmetic mean of these five targets is $15.80, rounded to $16, with a range of $14 to $18. Older mid-2026 targets remain higher in some data feeds—S&P Global's 10-analyst poll still reports a high near $24 and a mean near $16.90—reflecting revisions that predate the recent demand deterioration. The most current revisions cluster lower, which is why the central target here is based on the freshest figures.
Shares closed near $12.74 on October 16, 2026, after sliding from roughly $23 in July 2026 to the lower end of the 52-week range. Reaching $16 would require a move of about 25.6%, which is a substantial but not extreme gain for a cyclical chemicals name. The path likely depends on stabilization in TiO2 pricing, a normalization of refrigerant inventories, and evidence that recent cost cuts are flowing through to EBITDA (earnings before interest, taxes, depreciation, and amortization).
Several factors could help the stock re-rate toward $16. PFAS (per- and polyfluoroalkyl substances) litigation settlements have meaningfully reduced a long-standing legal overhang, and analysts note the company's balance-sheet and restructuring progress. Longer term, Chemours' Opteon low-global-warming-potential refrigerants stand to benefit from regulations phasing down older hydrofluorocarbons, and management has cited data-center immersion-cooling fluids as a market it estimates near $3 billion. A recovery in construction and coatings demand, or a reduction in Chinese TiO2 oversupply, would directly support the largest segment.
The principal obstacle is weak end-market demand. RBC's Arun Viswanathan cited sluggish construction and coatings activity, excess chemical supply from China, and customer inventory reductions in refrigerants as reasons to cut estimates—lowering full-year 2026 adjusted EBITDA to about $760 million and 2027 to roughly $900 million, below consensus. The firm's bearish scenario values shares near $8, while its bullish case reaches $21, underscoring the wide dispersion in outcomes. Second-quarter 2026 results also showed a $274 million GAAP net loss and an EPS (earnings per share) miss, leaving limited near-term valuation support if the macro cycle weakens further.
The stock's 52-week range spans roughly $9 to $29, and shares now trade near the low end after breaking below the prior $16–$18 zone. Near-term resistance sits in the $14–$16 area, which aligns with several recent analyst targets, while $18 marks the top of the current revision cluster. On the downside, the $10 psychological level and the 52-week low near $9 provide potential support. The steep decline means any sustained move toward $16 would likely require reclaiming and holding the $14 level first.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms vary. The most relevant near-term catalysts include the company's third-quarter earnings report, scheduled for October 28, 2026, plus guidance on TiO2 volumes, refrigerant destocking, and EBITDA. Investors should also watch for further analyst revisions, construction and coatings data, Chinese pigment supply dynamics, and any regulatory developments on low-GWP refrigerants.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, cyclically sensitive name like Chemours, these signals can help traders spot shifting momentum, monitor positions, and identify changing trends more efficiently than manual review alone. Explore the tool to see how AI-driven signals can support your own market monitoring.
The $16 target represents the mean of the five most recent analyst price targets, a level about 26% above the recent share price near $12.74. Reaching it is plausible if TiO2 demand stabilizes and refrigerant inventories normalize, but the narrow $14–$18 range among fresh revisions reflects genuine caution about a softening chemical cycle. The strongest supports are reduced legal risk and longer-term refrigerant and cooling opportunities, while weak end-market demand and potential valuation compression are the clearest obstacles. The October earnings report and subsequent analyst revisions will be the most important signals of whether the stock can rebuild toward $16.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CC has been closely correlated with TROX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CC jumps, then TROX could also see price increases.